These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 16778721

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories.
    Holland DT, DiFrancesco R, Stone J, Hamzeh F, Connor JD, Morse GD, Adult and Pediatric AIDS Clinical Trials Group Pharmacology Laboratory Committees, Pediatric AIDS Clinical Trials Group.
    Antimicrob Agents Chemother; 2004 Mar; 48(3):824-31. PubMed ID: 14982771
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Four years' experience in external proficiency testing programs for hair testing of drugs of abuse in Italy (HAIRVEQ) and comparison with the Society of Hair Testing program in 2005.
    Ventura M, Pichini S, Pujadas M, Ventura R, Di Giovannandrea R, Zuccaro P, Pacifici R, Langohr K, Jurado C, de la Torre R.
    Ther Drug Monit; 2007 Feb; 29(1):11-9. PubMed ID: 17304145
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Has compliance with CLIA requirements really improved quality in US clinical laboratories?
    Ehrmeyer SS, Laessig RH.
    Clin Chim Acta; 2004 Aug 02; 346(1):37-43. PubMed ID: 15234634
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. HAIRVEQ: an external quality control scheme for drugs of abuse analysis in hair.
    Pichini S, Ventura M, Pujadas M, Ventura R, Pellegrini M, Zuccaro P, Pacifici R, de la Torre R.
    Forensic Sci Int; 2004 Oct 29; 145(2-3):109-15. PubMed ID: 15451081
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nucleoside reverse transcriptase inhibitors and their phosphorylated metabolites in human immunodeficiency virus-infected human matrices.
    Lai J, Wang J, Cai Z.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun 01; 868(1-2):1-12. PubMed ID: 18472315
    [Abstract] [Full Text] [Related]

  • 12. Laboratory precision performance: state of the art versus operating specifications that assure the analytical quality required by clinical laboratory improvement amendments proficiency testing.
    Westgard JO, Bawa N, Ross JW, Lawson NS.
    Arch Pathol Lab Med; 1996 Jul 01; 120(7):621-5. PubMed ID: 8757464
    [Abstract] [Full Text] [Related]

  • 13. Quality improvement of diagnostic microbiology through a peer-group proficiency assessment program. A 20-year experience in Ontario. The Microbiology Committee.
    Richardson H, Wood D, Whitby J, Lannigan R, Fleming C.
    Arch Pathol Lab Med; 1996 May 01; 120(5):445-55. PubMed ID: 8639047
    [Abstract] [Full Text] [Related]

  • 14. Quality control and quality assurance.
    Laessig RH, Ehrmeyer SS, Hassemer DJ.
    Clin Lab Med; 1986 Jun 01; 6(2):317-27. PubMed ID: 3720254
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Performance goals for the laboratory testing of antithrombin, protein C and protein S.
    Meijer P, Haverkate F, Kluft C.
    Thromb Haemost; 2006 Nov 01; 96(5):584-9. PubMed ID: 17080214
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic DHPLC Quality Assurance (DDQA): a collaborative approach to the generation of validated and standardized methods for DHPLC-based mutation screening in clinical genetics laboratories.
    Schollen E, Dequeker E, McQuaid S, Vankeirsbilck B, Michils G, Harvey J, van den Akker E, van Schooten R, Clark Z, Schrooten S, Matthijs G, DDQA Collaborative Group.
    Hum Mutat; 2005 Jun 01; 25(6):583-92. PubMed ID: 15880509
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007.
    Shulgina MV, Malakhov VN, Hoffner SE, Haile M, Wright A.
    Int J Tuberc Lung Dis; 2009 Oct 01; 13(10):1294-300. PubMed ID: 19793436
    [Abstract] [Full Text] [Related]

  • 20. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
    Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A, Kuypers D, Le Meur Y, Marquet P, Oellerich M, Thervet E, Toenshoff B, Undre N, Weber LT, Westley IS, Mourad M.
    Ther Drug Monit; 2009 Apr 01; 31(2):139-52. PubMed ID: 19177031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.